We will perform studies to assess the number of regulatory T cells and tolergenic antigen presenting cells in patients with asthma.
Get early access to treatment options and help advance research for cancer and other diseases.
We will perform studies to assess the number of regulatory T cells and tolergenic antigen presenting cells in patients with asthma.
NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.